Articles On Anteo Diagnostics (ASX:ADO)

Title Source Codes Date
Why is AnteoTech’s (ASX:ADO) share price up ~10% today?

Summary ASX-listed surface chemistry company AnteoTech is working to facilitate the technology transfer for increasing manufacturing of its COVID-19 test. The Company has commenced the clinical trial of COVID-19 test with VIDRL. Anteo...

Kalkine Media ADO 3 years ago
AnteoTech Ltd (ASX:ADO) on track with Covid-19 test

24 Dec 2020 - AnteoTech (ASX:ADO) are pushing forward to release their Covid-19 antigen rapid test towards market launch.

FNN ADO 3 years ago
AnteoTech Share Price Jumps on Tax Incentive (ASX:ADO)

At the time of writing the AnteoTech Ltd [ASX:ADO] share price trades at 10.5 cents, up 5%. AnteoTech announced the company received a cash refund, under the Federal Government’s research and development tax incentive scheme... The post Ant...

MoneyMorning ADO 3 years ago
AnteoTech (ASX:ADO) to receive $1.2M tax refund

27 Nov 2020 - AnteoTech (ASX:ADO) has received a tax refund of almost $1.2 million under the Federal Government’s Research & Development Tax Incentive Scheme.

FNN ADO 3 years ago
Why the AnteoTech (ASX:ADO) share price is rocketing 28% higher

The AnteoTech Ltd (ASX: ADO) share price is rocketing higher today. This comes after the company announced a design freeze on its COVID-19 Antigen Rapid Test (ART) following successful results. At the time of writing, the Anteotech share p...

Motley Fool ADO 3 years ago
AnteoTech looking to clinical trial after receiving results of validation study

AnteoTech (ASX:ADO) says it has received the results of an independent validation study of its COVID-19 Antigen Rapid Test using stored patient swab samples.

BiotechDispatch ADO 3 years ago
AnteoTech (ASX:ADO) share price sinks 12% lower follow COVID-19 test update

The AnteoTech Ltd (ASX: ADO) share price has been a disappointing performer on Wednesday. In afternoon trade the biotech company’s shares are sinking 12% lower to 11 cents. Why is the Anteotech share price sinking lower? Investors have bee...

Motley Fool ADO 3 years ago
These fund managers are buying the dip, should you?

Buy the dip. Sound investment advice, or a mug’s game? Depending on your approach, it could fall to either side of that line. Timing the market to buy at the lows, or sell at the highs, is educated guess work at best. Which is why you’ll b...

Motley Fool ADO 3 years ago
AnteoTech Share Price Climbs 15% Higher on COVID-19 Test News

The good news keeps on coming for stocks working on COVID-19 treatments. The latest company to confirm some good news is AnteoTech Ltd [ASX:ADO]. A small-cap biotech firm that has been working on a product that tests for COVID-19 symptoms.....

MoneyMorning ADO 3 years ago
Anteotech (ASX:ADO) share price rockets 19% on COVID test announcement

The Anteotech Ltd (ASX: ADO) share price is up 18.75% in late afternoon trading, after initially leaping by nearly 23% this morning. The surge in the Anteotech share price comes on the heels of the company’s announcement to the ASX just af...

Motley Fool ADO 3 years ago
Scopo’s health powerplays: quick vaccine hits and cheap buys

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The market...

Stockhead ADO 3 years ago
AnteoTech Shares Emerges from Trading Halt 77% Higher (ASX:ADO)

AnteoTech Ltd’s [ASX:ADO] share price has rocketed up today after it emerged from a trading halt with news it will develop a COVID-19 detection platform. Shares in ADO are up 77.27% or 1.7 cents at the time of writing to trade at 3.9 cents...

MoneyMorning ADO 3 years ago
Closing Bell: Today’s biggest small cap movers on the ASX

A quick wrap of the ASX’s key winners and losers on Thursday, July 16. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. Today 604 stocks rose, 684 de...

Stockhead ADO 3 years ago
Another two ASX stocks enter the race for faster COVID-19 tests

One of the inconveniences of COVID-19 tests is that they can take several hours to complete. A number of ASX stocks are attempting to create faster tests, including two that surged this morning. AnteoTech Ltd (ASX:ADO), which said it has es...

Stockhead ADO 3 years ago
Rapid COVID-19 detection test sends AnteoTech shares soaring

Technologies developed in Brisbane and Melbourne may contribute to a new 15-minute test for COVID-19, harnessing nanocoating to speed up results for saliva and blood tests. Brisbane-based AnteoTech (ASX: ADO) has successfully developed a...

BusinessNewsAus ADO 3 years ago
AnteoTech unveils rapid and more accurate proof of concept COVID-19 test

Surface chemistry company AnteoTech (ASX: ADO) emerged from a trading halt this morning to announce a potential breakthrough in the struggle against COVID-19. The company revealed it has developed a proof of concept COVID-19 and flu multipl...

SmallCaps ADO 3 years ago
10 at 10: These ASX stocks are conquering the surf this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead ADO 3 years ago
Directors Trades: This anti-snoring device maker needed capital to survive COVID-19; one director put in $3.7m

2020 was looking good for many companies but COVID-19 changed all that. Some have needed capital to keep going and one was sleep apnoea mouthguard maker Somnomed (ASX:SOM). In February, the company reported solid revenue and operating profi...

Stockhead ADO 4 years ago
AnteoTech signs agreement with Merck to co-develop products for global point-of-care market

Queensland-based chemistry company AnteoTech (ASX: ADO) has signed a non-binding heads of agreement with German pharmaceutical and life sciences company Merck to co-develop products for the world’s rapidly-growing point of care diagnostic t...

SmallCaps ADO 4 years ago
AnteoTech (ASX:ADO) delivers solid quarter of development

AnteoTech (ADO) has delivered a solid quarter of development and advanced key business relationships The company’s new cross-linked binder development is progressing quickly and has gathered market interest Feedback will be used for coll...

themarketherald.com.au ADO 4 years ago
Who changed their name in 2019?

There are many reasons why a company might change its name, from being taken over to hiding a shady past. This year 114 companies have changed their name. Family cyber security provider Wangle Technologies became the much more fitting Famil...

Stockhead ADO 4 years ago
6 ASX listed Small cap Stocks – FFG, SM8, RWD, AUZ, ADO, GID

Small cap stocks comprise of the entities with small market capitalisation. They often provide an edge to individual investors over institutional investors, since they choose to buy large-cap stocks that are deemed as stable ones. However,...

Kalkine Media ADO 4 years ago
AnteoTech partners with US company to develop point-of-care products using AnteoBind coatings

Chemistry and coating company AnteoTech (ASX: ADO) has signed a commercial agreement with IMRA America Inc for the joint development of AnteoBind-coated gold particles to be used in point-of-care diagnostics. Under the agreement, AnteoTech...

SmallCaps ADO 4 years ago
A Lens Over Diversified Stocks: Screening Through LNU, ADO, AD1, ZNO, ESH, IHR

Diversification Investing across multiple asset classes, sectors and geographies help an investor to manage their risks effectively. It supports in narrowing down an array of results between anticipated and the best return from an investmen...

Kalkine Media ADO 4 years ago
Directors Trades: When you’re forced to sell because of the ‘Taxman’

Last week appeared to be a good time to buy, judging by the number of trades above $100,000; but two directors not only couldn’t buy, but had to sell. Why? The Taxman. Kogan’s (ASX:KGN) Harry Debney sold nearly $1m of stock to pay a tax bi...

Stockhead ADO 4 years ago
Anteo Diagnostics appoints new CEO

Anteo Diagnostics (ASX:ADO) has announced the appointment of Derek Thomson as its new chief executive officer.

BiotechDispatch ADO 4 years ago
RESEARCH: Potential Lithium-Ion Battery Revolutionary

Anteo Diagnostics: Recharging the batteries By Pitt Street Research A potential Lithium-Ion Battery Revolutionary Anteo Diagnostics ((ADO)), having developed what is arguably the world’s most versatile surface modification technology, spent...

FNArena ADO 4 years ago
Latest Updates on Four Healthcare Stocks – SOM, ADO, VHT, IMU

Health and medical industry of Australia focuses on the world’s leading technology, advanced research, development and innovation. Over the years, the industry has registered strong growth in terms of both size and reputation. Let us discus...

Kalkine Media ADO 4 years ago
Anteo will collaborate with a ‘globally recognised battery anode producer’

Anteo Diagnostics’s (ASX:ADO) nano-coating tech has caught the attention of another major player in the global lithium-ion supply chain. The Anteo silicon-based tech could support the production of lithium-ion batteries with up to 75 per ce...

Stockhead ADO 4 years ago
Three Penny Stocks That Are In The News- ADO, KTD And FZO

Penny stocks are those stocks that trade at a meagre price usually less than A$1.00, and the company has a very low market capitalization, below A$300 million. These kinds of stocks are characterised by high volatility and thus are consider...

Kalkine Media ADO 4 years ago
Anteo signs new agreement with Lumos Diagnostics

Anteo Diagnostics (ASX:ADO) has signed a collaboration agreement with California based Point-of-Care (POC) company Lumos Diagnostics.

BiotechDispatch ADO 4 years ago